Author

Yue Huang

AstraZeneca (United Kingdom)ORCID 0000-0002-0864-8990Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yue Huang2 papers · Capital Medical University

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

Anton I. RosenbaumiD· 1 shared B. Timothy HummeriD· 1 shared ChaoYu Jin· 1 shared Joseph S. GrimsbyiD· 1 shared Kristina S. KovacinaiD· 1 shared Meina LiangiD· 1 shared Ruipeng Mu· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anton I. RosenbaumORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintMay 30, 2024

Inhibition of Endothelial Lipase by MEDI5884 Normalizes Phosphatidylinositol Levels in Coronary Artery Disease Patients

Anton I. Rosenbaum, Yue Huang, Ruipeng Mu…·Joseph S. Grimsby

This study shows that MEDI5884 increases phosphatidylinositol levels in CAD patients by inhibiting endothelial lipase, correlating with improved HDL function and reverse cholesterol transport.

1 citation

humannon-human primate

𝕏 PostBluesky